MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 94 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $265,000 | +147.7% | 104,300 | +97.2% | 0.00% | – |
| Q1 2020 | $107,000 | +98.1% | 52,900 | +110.8% | 0.00% | – |
| Q4 2019 | $54,000 | +38.5% | 25,100 | 0.0% | 0.00% | – |
| Q3 2019 | $39,000 | -62.5% | 25,100 | 0.0% | 0.00% | – |
| Q2 2019 | $104,000 | +55.2% | 25,100 | +55.9% | 0.00% | – |
| Q1 2019 | $67,000 | -17.3% | 16,100 | -42.9% | 0.00% | – |
| Q4 2018 | $81,000 | -71.3% | 28,200 | 0.0% | 0.00% | – |
| Q3 2018 | $282,000 | +91.8% | 28,200 | +35.6% | 0.00% | – |
| Q2 2018 | $147,000 | – | 20,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management III, LLC | 5,016,164 | $10,835,000 | 2.15% |
| Bain Capital Life Sciences Investors, LLC | 5,942,735 | $12,836,000 | 1.91% |
| Asymmetry Capital Management, L.P. | 354,853 | $766,000 | 1.37% |
| Lion Point Capital, LP | 6,374,740 | $13,769,000 | 1.28% |
| Granite Point Capital Management, L.P. | 2,700,000 | $5,832,000 | 0.91% |
| VHCP Management II, LLC | 1,486,676 | $3,211,000 | 0.85% |
| Boxer Capital, LLC | 4,800,000 | $10,368,000 | 0.59% |
| Avoro Capital Advisors LLC | 6,200,000 | $13,392,000 | 0.39% |
| 683 Capital Management, LLC | 925,382 | $1,999,000 | 0.23% |
| Islet Management, LP | 875,000 | $1,890,000 | 0.18% |